1. Home
  2. BOLT vs BOF Comparison

BOLT vs BOF Comparison

Compare BOLT & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • BOF
  • Stock Information
  • Founded
  • BOLT 2015
  • BOF 2017
  • Country
  • BOLT United States
  • BOF United States
  • Employees
  • BOLT N/A
  • BOF N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • BOF Packaged Foods
  • Sector
  • BOLT Health Care
  • BOF Consumer Staples
  • Exchange
  • BOLT Nasdaq
  • BOF Nasdaq
  • Market Cap
  • BOLT 16.8M
  • BOF 18.3M
  • IPO Year
  • BOLT 2021
  • BOF 2023
  • Fundamental
  • Price
  • BOLT $0.35
  • BOF $2.29
  • Analyst Decision
  • BOLT Hold
  • BOF
  • Analyst Count
  • BOLT 5
  • BOF 0
  • Target Price
  • BOLT $1.00
  • BOF N/A
  • AVG Volume (30 Days)
  • BOLT 103.8K
  • BOF 62.2K
  • Earning Date
  • BOLT 05-12-2025
  • BOF 05-27-2025
  • Dividend Yield
  • BOLT N/A
  • BOF N/A
  • EPS Growth
  • BOLT N/A
  • BOF N/A
  • EPS
  • BOLT N/A
  • BOF N/A
  • Revenue
  • BOLT $3,638,000.00
  • BOF $6,516,337.00
  • Revenue This Year
  • BOLT N/A
  • BOF N/A
  • Revenue Next Year
  • BOLT $77.48
  • BOF N/A
  • P/E Ratio
  • BOLT N/A
  • BOF N/A
  • Revenue Growth
  • BOLT N/A
  • BOF 130.60
  • 52 Week Low
  • BOLT $0.30
  • BOF $0.61
  • 52 Week High
  • BOLT $1.34
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 45.53
  • BOF 65.79
  • Support Level
  • BOLT $0.35
  • BOF $1.92
  • Resistance Level
  • BOLT $0.38
  • BOF $2.38
  • Average True Range (ATR)
  • BOLT 0.03
  • BOF 0.11
  • MACD
  • BOLT 0.00
  • BOF 0.04
  • Stochastic Oscillator
  • BOLT 29.16
  • BOF 82.82

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: